Emma Niméus

7PUBLICATIONS
46CO-AUTHORS
Cell development, proliferation and deathPredictive and prognostic markersTumour immunologyRadiation therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 26, 2025
Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division.

Hien Bui, Simon Andersson, Agustin Sola-Carvajal

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Apr 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.

Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus

|Mar 28, 2023
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Moa Egelberg, Tommaso De Marchi, Gyula Pekar

|Feb 02, 2023
Proteogenomics decodes the evolution of human ipsilateral breast cancer.

Tommaso De Marchi, Paul Theodor Pyl, Martin Sjöström

|Apr 20, 2022
A somatic mutation in moesin drives progression into acute myeloid leukemia.

Ouyang Yuan, Amol Ugale, Tommaso de Marchi

Pageof 2

Frequent Collaborators

4 joint publications

Erik Holmberg

4 joint publications

Per Karlsson

4 joint publications

Fredrika Killander

4 joint publications

Tommaso de Marchi